3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Stomach Neoplasms
5
Hyperphagia
3
Pancreatic Neoplasms
2
Malnutrition
2
Neutropenia
1
Neoplasms
1
Mucositis
1
Leukemia, Myeloid, Acute
1
Infections
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis
1
Carcinoma, Hepatocellular
1
Adenocarcinoma Of Esophagus
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
9
Ciprofloxacin
7
Voriconazole
5
Caspofungin
4
Amoxicillin-Potassium Clavulanate Combination
4
gamma-Globulins
3
Vancomycin
3
Fluconazole
3
Filgrastim
3
Daptomycin
3
Antibiotic Prophylaxis
3
plerixafor
2
liposomal amphotericin B
2
Trimethoprim
2
Therapeutics
2
Sulfamethoxazole
2
Saline Solution
2
Ribavirin
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Pentetic Acid
2
Moxifloxacin
2
Melphalan
2
Levofloxacin
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Granulocyte Colony-Stimulating Factor
2
Ethanol
2
Cyclophosphamide
2
Cefazolin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Infections
×
fish oil triglycerides
×
Clear all
NCT00533078
2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2
Completed
14 enrolled